Pacira BioSciences
PCRX----
Pacira BioSciences (PCRX)
Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health soluti...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
- 52wk Low
- --
- Float Mkt Cap
- --
- Market Cap
- --
- P/ETTM
- --
- P/EDynamic
- --
- P/EStatic
- --
- EPSTTM
- --
- EPSDynamic
- --
- EPSStatic
- --
- BVPS
- --
- P/B
- --
- Circulating Supply
- --
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- --
- Min lot size
- --
- Currency
- --
Pacira BioSciences Analyst Rating
View moreForecast & Rating
Oct 12, 2026Price forecast
$33.57-7.64%
Forecast & RatingHold
9analysts
- Strong buy11.11%
- Buy0.00%
- Hold88.89%
- Sell0.00%
- Strong sell0.00%
News
- PR Newswire ·
Are OPCH, PCRX, RXO, BOLD Obtaining Fair Deals for their Shareholders?
- prnewswire ·
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Pacira BioSciences, Inc. (NASDAQ: PCRX)
- Seeking Alpha ·
Notable healthcare headlines for the week: Novavax, Moderna and Becton Dickinson in focus
